Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form
D-Scholarship @ Pitt Banner and Links to Homepage

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1

Mascola, JR and Snyder, SW and Weislow, OS and Belay, SM and Belshe, RB and Schwartz, DH and Clements, ML and Dolin, R and Graham, BS and Gorse, GJ and Keefer, MC and McElrath, MJ and Walker, MC and Wagner, KF and McNeil, JG and McCutchan, FE and Burke, DS (1996) Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. Journal of Infectious Diseases, 173 (2). 340 - 348. ISSN 0022-1899

[img] Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)

Abstract

Phase I studies of volunteers not infected with human immunodeficiency virus type 1 (HIV-1) have shown that immunization with envelope subunit vaccine products elicits antibodies that neutralize laboratory-adapted (prototype) HIV-1 strains in vitro. Prototype strains are adapted to grow in continuous (neoplastic) cell lines and are more susceptible to neutralization than are primary isolates cultured in human peripheral blood mononuclear cells. In this study, 50 sera from nine phase I vaccine trials and 16 from HIV-1-infected persons were evaluated for neutralizing antibody activity against 3 laboratory-adapted and 5 primary HIV-1 isolates. Of 50 sera, 49 neutralized at least 1 of the prototype strains: however, none displayed neutralizing activity against primary isolates of HIV-1. Serum from most HIV- 1-infected persons neutralized both laboratory-adapted and primary HIV-1 isolates. These data demonstrate a qualitative, or large quantitative, difference in the neutralizing antibody response induced by envelope subunit vaccination and natural HIV-1 infection.

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Mascola, JR
Snyder, SW
Weislow, OS
Belay, SM
Belshe, RB
Schwartz, DH
Clements, ML
Dolin, R
Graham, BS
Gorse, GJ
Keefer, MC
McElrath, MJ
Walker, MC
Wagner, KF
McNeil, JG
McCutchan, FE
Burke, DSdonburke@pitt.eduDONBURKE
Centers: Other Centers, Institutes, Offices, or Units > Center for Vaccine Research
Date: 1 January 1996
Date Type: Publication
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Journal or Publication Title: Journal of Infectious Diseases
Volume: 173
Number: 2
Page Range: 340 - 348
DOI or Unique Handle: 10.1093/infdis/173.2.340
Institution: University of Pittsburgh
Schools and Programs: School of Public Health > Epidemiology
Refereed: Yes
ISSN: 0022-1899
Date Deposited: 05 May 2015 16:52
Last Modified: 19 Jan 2019 15:55
URI: http://d-scholarship.pitt.edu/id/eprint/24310

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

Actions (login required)

View Item View Item